The effect of a brinzolamide/brimonidine fixed combination on optic nerve head blood flow in rabbits
PLOS ONE · 2023
DOI: 10.1371/journal.pone.0295122 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Nana Takahashi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Tohoku University Graduate School of Medicine, Miyagi, Japan. Hauptthemen laut MEDLINE: Optic Disk, Glaucoma, Open-Angle, Ocular Hypertension. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Senju Pharmaceutical Co., Ltd..
Abstract (Originalsprache)
Purpose
The purpose of this study was to investigate the effect of a 1% brinzolamide and 0.1% brimonidine fixed combination (BBFC) on ONH blood flow (BF) in rabbits.
Methods
A crossover study was conducted on pigmented rabbits; a physiological saline solution, brinzolamide, or BBFC was administered for eight days. ONH BF, intraocular pressure (IOP) and systemic parameters were measured before the eighth day’s first dose and at 6, 9, 12, and 14 hours after the dose. ONH BF was assessed using laser speckle flowgraphy, and mean blur rate (MBR) values were calculated. The percentage against baseline of each parameter was calculated, and intergroup comparisons were performed at each time point.
Results
There were no significant differences in the percentage change in systemic parameters. At 6 hours after administration, the BBFC group showed a significantly higher percentage change in large vessel area-MBR (%MV) compared to the control group (98.6±16.8%MV vs. 81.3±7.9%MV, P = 0.03). On the other hand, the brinzolamide group did not show a significant difference. Both the brinzolamide and BBFC groups had significantly lower percentage change in IOP (%IOP) compared to the control group (90.6±5.0%IOP, 93.3±2.9%IOP, and 99.2±1.7%IOP, respectively, P < 0.01).
Conclusion
BBFC effectively reduces IOP and mitigates diurnal fluctuation-induced decreases in ONH BF.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, Tohoku University Graduate School of Medicine, Miyagi, Japan.
- Department of Advanced Ophthalmic Medicine, Tohoku University Graduate School of Medicine, Miyagi, Japan.
- Seiryo Eye Clinic, Miyagi, Japan.
- Department of Research and Development Division, Senju Pharmaceutical Co., Ltd., Osaka, Japan.
- Department of Ophthalmic Imaging and Information Analytics, Tohoku University Graduate School of Medicine, Miyagi, Japan.
- Department of Retinal Disease Control, Tohoku University Graduate School of Medicine, Miyagi, Japan.
ORCID-Profile: Nana Takahashi, Toru Nakazawa
Förderung
- Senju Pharmaceutical Co., Ltd.
Zitieren
APA
Takahashi, N., Sato, K., Kiyota, N., Yamazaki, M., Kunikane, E., & Nakazawa, T. (2023). The effect of a brinzolamide/brimonidine fixed combination on optic nerve head blood flow in rabbits. PLOS ONE. https://doi.org/10.1371/journal.pone.0295122
Vancouver
Takahashi N, Sato K, Kiyota N, Yamazaki M, Kunikane E, Nakazawa T. The effect of a brinzolamide/brimonidine fixed combination on optic nerve head blood flow in rabbits. PLOS ONE. 2023. doi:10.1371/journal.pone.0295122
BibTeX
@article{Takahashi2023,
author = {Takahashi, Nana and Sato, Kota and Kiyota, Naoki and Yamazaki, Mai and Kunikane, Eriko and Nakazawa, Toru},
title = {The effect of a brinzolamide/brimonidine fixed combination on optic nerve head blood flow in rabbits},
journal = {PLOS ONE},
year = {2023},
doi = {10.1371/journal.pone.0295122}
}
EUVIMED